Second- and third-generation drugs for immuno-oncology treatment—The more the better?
Year: 2017
Type: review
Source: European Journal of Cancer
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2587536205
